In a report released yesterday, Canaccord Genuity also maintained a Buy rating on the stock with a $8.00 price target. See the top stocks recommended by analysts >> The company has a one-year high of $3.12 and a one-year low of $0.70. Currently, Cardiol Therapeutics has an average ...